-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Exploring the ‘Omics of Cardiovascular and Renal Sequelae of Sickle Cell Disease

Program: Scientific Workshops @ ASH
Friday, December 4, 2020: 8:15 AM-9:05 AM
No relevant conflicts of interest to declare.
This session will include three presentations focused on current work using ‘omics to inform cardiovascular and renal pathophysiology, which are highly correlated in SCD. Further, these outcomes are associated with risk for early mortality and therefore are of significant import to patient quality of life and survival. Dr. Gladwin will discuss the use of multiple omics to understand hemolytic anemia and transfusion medicine as they relate to cardiopulmonary outcomes in SCD. Dr. Ashley-Koch will discuss recent application of multiple omics to dissect risk for sickle nephropathy. Finally, Dr. Nekhai will discuss the use of urinary proteomics to understand sickle nephropathy.

Allison Ashley-Koch, PhD

Department of Medicine, Duke University Medical Center, Durham, NC

Sergei Nekhai, PhD

Center for Sickle Cell Disease and Department of Medicine, Howard University, Washington, DC